Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease

BACKGROUND AND OBJECTIVE: Adult-onset Still’s disease (AOSD) is an idiopathic systemic inflammatory disease of unknown aetiology. Some patients exhibit resistance to conventional treatment during long-term therapy. Janus kinase inhibitors (JAKinibs) may contribute to the improvement in AOSD symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ziyi, Li, Rongqi, Wang, Yingai, Han, Feng, Wei, Wei, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293510/
https://www.ncbi.nlm.nih.gov/pubmed/37010773
http://dx.doi.org/10.1007/s40268-023-00417-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293510/
https://www.ncbi.nlm.nih.gov/pubmed/37010773
http://dx.doi.org/10.1007/s40268-023-00417-7

Ejemplares similares